Clinical Trial Update: Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Stanford investigating single-dose N-acetylcysteine for autism spectrum disorder, focusing on restricted/repetitive behaviors; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Stanford University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: RECRUITING